Basel, February 25, 2019 – Novartis announced today that it is exercising its option to license the rights to develop and commercialize TQJ230, an investigational agent previously known as AKCEA-APO(a)-LRx, from Akcea Therapeutics, an affiliate of Ionis Pharmaceuticals, for targeted cardiovascular therapy. TQJ230 was discovered by Ionis and has been co-developed to […]
Other News
4C Medical’s Novel Mitral Regurgitation Therapy to be Highlighted at CRT 2019 Meeting
BROOKLYN PARK, Minn., Feb. 25, 2019 /PRNewswire/ — 4C Medical Technologies, Inc. (4C Medical), a developer of minimally invasive technologies for structural heart disease, today announced that its AltaValve™, a transcatheter mitral valve replacement (TMVR) technology, will be highlighted in the following presentations at the Cardiovascular Research Technologies (CRT) meeting held March 2-5, 2019 in Washington, […]
Texas Cardiac Arrhythmia Institute at St. David’s Medical Center enrolling patients to test stroke-reducing device
AUSTIN, Texas, Feb. 25, 2019 /PRNewswire/ — The Texas Cardiac Arrhythmia Institute at St. David’s Medical Center recently began enrolling patients to participate in the DIAMOND-AF II clinical trial to examine the effectiveness of the DiamondTemp System in treating patients with persistent atrial fibrillation, or A Fib. A Fib is a type of […]
Nihon Kohden Appoints New CEO of North American Operations
IRVINE, Calif.–(BUSINESS WIRE)–Nihon Kohden, a U.S. market leader in precision medical products and services, today announced the appointment of Yasuhiro Yoshitake as its new president and CEO. Yoshitake is taking over the helm of the organization from Dr. Wilson P. Constantine, who led the organization from April 2015 to February […]
LivaNova’s Perceval Sutureless Aortic Heart Valve Receives National Reimbursement in Japan to Treat Patients with Aortic Valve Disease
LONDON–(BUSINESS WIRE)–LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology company, today announced that Japan’s Ministry of Health, Labour and Welfare granted national reimbursement for the Company’s Perceval® sutureless aortic heart valve to treat aortic valve disease. By adding Perceval into Japan’s health insurance system, physicians and patients have greater access to this […]
Integer Holdings Corporation Reports Results for Fourth Quarter and Full Year 2018
PLANO, Texas, Feb. 21, 2019 (GLOBE NEWSWIRE) — Integer Holdings Corporation (NYSE:ITGR), a leading medical device outsource manufacturer, today announced results for the fourth quarter and fiscal year ended December 28, 2018. Fourth Quarter 2018 Highlights GAAP Sales from continuing operations increased 0.3% and Non-GAAP Sales from continuing operations increased […]
Acasti Pharma Recognized in TSX Venture Exchange’s 2019 Venture 50
LAVAL, Quebec, Feb. 21, 2019 (GLOBE NEWSWIRE) — Acasti Pharma Inc. (“Acasti” or the “Company”) (NASDAQ: ACST – TSX-V: ACST), a biopharmaceutical innovator focused on the research, development and commercialization of its prescription drug candidate CaPre® (omega-3 phospholipid) for the treatment of severe hypertriglyceridemia, announces it has been recognized by […]
Neovasc Celebrates 5-Year Anniversary of Tiara Patient as the Longest Surviving Transcatheter Mitral Valve Replacement in the World
VANCOUVER, Feb. 21, 2019 /PRNewswire/ – Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ: NVCN) (TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies and in the development of minimally invasive devices for the treatment of refractory angina, today announced that a patient implanted with a Tiara™ transcatheter […]
Rebirth of a Heart Valve: Franciscan Health Surgeon First in World to Use Device
INDIANAPOLIS, Feb. 21, 2019 /PRNewswire/ — A patient who received a first-in-the-world tricuspid valve procedure as part of a new national clinical trial at Franciscan Health Heart Center is home and recovering well. The procedure utilizes a revolutionary material called extracellular matrix. The material provides a seamless valve structure which engages and […]
Teleflex Reports Fourth Quarter and Full Year 2018 Results; Provides 2019 Guidance
WAYNE, Pa.–(BUSINESS WIRE)–Teleflex Incorporated (NYSE: TFX) (the “Company”) today announced financial results for the fourth quarter and full year ended December 31, 2018. Fourth quarter 2018 net revenues were $641.6 million, an increase of 7.8% compared to the prior year period. Excluding the impact of foreign currency exchange rate fluctuations, […]
Recent
Ancora Heart Inc. Reports Two-Year Results Demonstrating Sustained Benefits of AccuCinch® System in Heart Failure Patients
Cardiawave Strengthens Leadership with Appointment of Jonathan Freeman as Board Chairman
AngioInsight Appoints Medtech Veteran Shlomi Nachman to Board of Directors; Announces Series A Round to Accelerate AI-Driven Advancement in Cardiology
Popular
- No commented posts yet